1Russell KL,Hawksworth AW,Ryan MA,et al. Vac- cine-preventable adenoviral respiratory illness in US military recruits, 1999-2004 [J]. Vaccine, 2006, 24(15):2835-2842.
2Henaff D,Salinas S,Kremer EJ. An adenovirus traffic update : from receptor engagement to the nuclear pore [J]. Future Microbio1,2011,6(2) : 179-192.
3Jones MS,Harrach B,Ganac RD,et al. New adenovi- rus species found in a patient presenting with gas- troenteritis [J].J Virol, 2007,81 (11) : 5978-5984.
4Russell WC. Adenoviruses:update on structure and function[J].J Gen Virol, 2009,90 (1) : 1-20.
6Ma H, Liu Y, Liu S,et al. Oral adeno-associated vi- rus-sTRAIL gene therapy suppresses human hepato- cellular carcinoma growth in mice [J].Hepatology ,2005,42(6):1355-1363.
7Shimony N,Elkin G,Kolodkin-Gal D,et al. Analysis of adenoviral attachment to human platelets[J].Virol J,2009,6(1) :25.
8Roelvink PW,Lizonova A,Lee JG,et al. The coxsae- kievirus-adenovirus receptor protein can function as a cellular attachment protein for adenovirus serotypesfro msubgroups A,C,D,E and F[J].J Virol, 1998,72 (10):7909-7915.
9Othman M,Labelle A, Mazzetti I, et al. Adenovirus- induced thrombocytopenia: the role of von-Wille- brand factor and P-selectin in mediating acceleratedplatelet clearance [J]. Blood, 2007, 109 (7) : 2832- 2839.
10Escutenaire S, Cerullo V, Diueonu I, et al. In vivo and in vitro distribution of type 5 and fiber-modified oncolytic adenoviruses in human blood compart-ments [J]. Ann Med ,2011,43(2) : 151-163.
